Registration

Inauguration Ceremony

Lighting of the Lamp
National Anthem

• Opening remarks – Dr Rajeev Singh Raghuvanshi, DCGI
• Welcome Address by Shri Namit Joshi, Chairman Pharmexcil
• Address by Shri Mohit Yadav, IFS, Joint Secretary, Department of Commerce, EP(Pharma)
• Address by Ms. Punya Salila Srivastava, IAS, Secretary, DoHFW
• *Key Note Speech by Chief Guest, Shri J.P. Nadda ji, Honorable Minister of Health and Family Welfare (MoHFW), Govt. of India
• Vote of Thanks – Shri Raja Bhanu, Director General, Pharmexcil

Tea Break

Session 1 Regulatory Reforms in India: Building a Modern, Trusted and Efficient Medicines Ecosystem

• Presentation by Dr. Rajeev Singh Raghuvanshi, DCGI, CDSCO
• Presentation by Mr. Namit Joshi, Chairman, PHARMEXCIL

Session 2 Fireside Chat: Indian Pharma Industry – Affordable Generics to Frugal innovation

Indian pharma industry leaders will share their experiences

Moderator: Mr. Viranchi Shah, President, IDMA

Panellists:

• Mr. Mehul Shah, Chairman & Managing Director, Encube Ethicals
• Mr Mukul Jain, President – ZRC Biology, Zydus Lifesciences Ltd.
• Dr Murali Ramachandra – Chief Executive Officer, Aurigene Oncology Ltd.
• Dr Ms Yashoraj Zala – SVP & Head - Drug Delivery Systems, Sun Pharmaceutical Industries Ltd.
• Dr. Mahesh V Patel Chief Scientific Officer, Wockhardt Ltd.
• Prof Rahul Purwar – Founder & Chairman, ImmunoACT; Professor, IIT Bombay

Lunch Break

Session 3 Partners in Quality: Meeting Importer Expectation through Exporter Excellence

A panel discussion on the quality expectations of the Importers and exporters. Visiting Regulators, CDSCO official and Pharmexcil representatives will participate.

Moderator:

• Mr. Namit Joshi, Chairman, Pharmexcil

Panellists:

• Mr. Bhavin Mehta, Director, Kilitch Drugs
• Dr. George A. Patani, Senior Vice President, IDMA
• Dr. Rubina Bose, DDC(I), CDSCO
• Dr. Olugbenga Timothy Fajemirokun, Special Assistant to the DG, NAFDAC
• Dr. Ainur Kydyralieva, Fellow Research/National Medicines Regulatory Expertsity Kyrgyzstan
• Mr. Greg Smith, Country Director US-FDA

Session 4 Pharmacopeia – Recognition, Global harmonization, next possibilities

Presentation by the Indian Pharmacopoeia Commission followed by the panel discussion with visiting regulators sharing their experience in recognizing Indian Pharmacopoeia.

Moderator:

• Dr. Milind Joshi, IDMA,

Panellist:

• Dr. Gaurav Pratap Singh, Senior Principal Scientist, Indian Pharmacopoeia Commission send an email.
• Mr. Sudarshan Jain, SG, IPA
• Dr. Chandrashekar Ranga, Joint Drugs Controller (India), CDSCO
• Dr. T S Parmar Secretary General, IDMA
• Mr. Kaushik Desai, Industry Representative, International Pharmaceutical Excipients Council (IPEC)
• Zukiswa Segametsi Raditladi, Director Licensing and Enforcement, Botswana
• Dr. Werawatte Kankanamalage Chaminda Prabhath, CEO, National Medicines Regulatory Authority Sri Lanka, Sri Lanka

Tea Break and Networking

Session 5 Trust, Reliance and Regulatory Convergence- Removing Barriers for faster Access to Quality Medicines

Moderator:

• Mr Anil Arora, Ex-industry

Panellists:

• Dr Mandy Budwal-Jagait, Interim Deputy Director for Standarand Compliance, UKMHRA
• Dr. Annam Visala, Joint Drugs Controller (India), CDSCO
• Dr. Kampadilemba Ouoba, Director of Health Products Vigilance, National Drug Regulatory Authority (ANRP),
• Mr. Daisuke Koga, Director, Office of International Strategy and Planning, Japan
• Ms. Lisette Pérez Ojeda, Advisor, CECMED, Cuba
• Ms. Nazalia Leonardo Macuvele, Director of Evaluation Medicine and Health Products Division, Mozambique
• Dr. Olugbenga Timothy Fajemirokun, Special Assistant to the DG, NAFDAC

Cultural Program, Networking and Dinner